฿27.75 ($0.83)

+0.50 (+1.83%)

Weekly Expected Move ±3.7%

฿26 ฿27 ฿28 ฿29 ฿30

SET · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 44 · ฿6.1B mcap · 55M float · 0.951% daily turnover

Analysis Technicals Weather Peers

Revenue

$3.6B +19.2% ▲

5Y CAGR: +28.9%

Gross Profit

$1.8B +16.5% ▲

5Y CAGR: +24.8%

Operating Income

$464M +16.4% ▲

5Y CAGR: +22.4%

Net Income

$364M +12.9% ▲

5Y CAGR: +20.2%

EPS (Diluted)

$1.65 +13.0% ▲

5Y CAGR: +20.1%

EBITDA

$791M +14.8% ▲

5Y CAGR: +26.3%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$950M	$1.6B	$2.3B	$3.0B	$3.6B
YoY Growth	-5.1%	+72.5%	+39.4%	+30.6%	+19.2%
Cost of Revenue	$391M	$716M	$1.0B	$1.4B	$1.8B
Gross Profit	$559M	$923M	$1.2B	$1.5B	$1.8B
Gross Margin	58.8%	56.3%	54.0%	51.7%	50.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$408M	$674M	$903M	$1.2B	$1.3B
Operating Expenses	$406M	$667M	$890M	$1.1B	$1.3B
Operating Income	$153M	$256M	$345M	$399M	$464M
Operating Margin	16.1%	15.6%	15.1%	13.4%	13.0%
Interest Expense	$4M	$11M	$15M	$24M	$26M
Income Before Tax	$149M	$246M	$350M	$391M	$461M
Tax Expense	$20M	$41M	$62M	$69M	$97M
Net Income	$129M	$205M	$289M	$322M	$364M
Net Margin	13.6%	12.5%	12.6%	10.8%	10.2%
EPS (Diluted)	$0.59	$0.93	$1.31	$1.46	$1.65
EBITDA	$234M	$398M	$560M	$689M	$791M
Shares Outstanding	220M	220M	220M	220M	220M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$750M	$844M	$814M	$851M	$878M	$1.0B	$1.1B	$1.1B
Cost of Revenue	$364M	$388M	$401M	$419M	$444M	$496M	$526M	$550M
Gross Profit	$386M	$456M	$413M	$432M	$433M	$518M	$560M	$577M
Gross Margin	51.5%	54.0%	50.8%	50.8%	49.4%	51.1%	51.6%	51.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$294M	$335M	$306M	$316M	$330M	$381M	$405M	$432M
Operating Expenses	$293M	$330M	$303M	$315M	$329M	$381M	$405M	$432M
Operating Income	$93M	$126M	$110M	$117M	$104M	$137M	$155M	$145M
Operating Margin	12.4%	14.9%	13.5%	13.8%	11.9%	13.5%	14.3%	12.8%
Interest Expense	$6M	$6M	$6M	$7M	$7M	$7M	$7M	$7M
Income Before Tax	$90M	$123M	$107M	$114M	$100M	$141M	$155M	$143M
Tax Expense	$16M	$24M	$22M	$24M	$21M	$30M	$34M	$31M
Net Income	$74M	$99M	$85M	$89M	$79M	$111M	$121M	$112M
Net Margin	9.9%	11.7%	10.4%	10.5%	9.0%	10.9%	11.2%	9.9%
EPS (Diluted)	$0.34	$0.45	$0.39	$0.41	$0.36	$0.50	$0.55	$0.51
EBITDA	$170M	$208M	$192M	$198M	$194M	$221M	$245M	$239M
Shares Outstanding	218M	218M	217M	218M	219M	220M	220M	220M

KLINIQ.BK SET